Examining the Impact of Opium Use on COVID-19 Severity and Outcomes - Top-Institutions - MDSpire

Examining the Impact of Opium Use on COVID-19 Severity and Outcomes

  • By

  • Fatemeh Amin

  • Hamid Ostadebrahimi

  • Najmeh Parvaz

  • Hadi Eslami

  • Haniyeh Maleki

  • Somayeh Kazempour

  • January 30, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Addiction Medicine
    • Infectious Diseases
    • Immunology

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Addiction Medicine
    • Pulmonology
    • Infectious Diseases

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Addiction Medicine
    • Immunology
    • Infectious Diseases

  • #4

    National Institute on Drug Abuse (NIDA), NIH
    National Institute on Drug Abuse (NIDA), NIH

    Bethesda, MD

    Key Differentiators

    • Addiction Medicine
    • Public Health
    • Immunology

  • #5

    University of Oxford
    University of Oxford

    Oxford, UK

    Key Differentiators

    • Addiction Medicine
    • Infectious Diseases
    • Immunology

Original Source(s)

Examining the Impact of Opium Use on COVID-19 Severity and Outcomes

  • by Fatemeh Amin, Hamid Ostadebrahimi, Najmeh Parvaz, Hadi Eslami, Haniyeh Maleki, Somayeh Kazempour

  • January 30, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Bereavement Tied to Higher Cardiovascular Risk

Acute post-loss period and pandemic conditions each amplified cardiovascular vulnerability in nationwide Swedish cohort study.

Rare COVID Vaccine Clotting Linked to Adenoviral Protein 

Antibody proteomics and immunogenetics identify adenoviral protein VII as the trigger of PF4-targeting antibodies 

  • April 21, 2026

  • 2 min